Ann: Incannex engages Procaps to produce IHL-42X, page-9

Great news- not a surprise should I say?

The surprise is that the phase 2 and 3 are going to be open label trials per the Ann!

Also based on timelines provided, 6 months of follow-up from the “open label extension to the phase 2 clinical trial” which was announced on 22/7/21, this gives us a timeline of Jan-Feb 2022 when we should expect the results of the trials. This is noting that the first phase kicked off months prior to it but they may await the results from this extension phase and publish results jointly.

Great going IHL team!